Summary:
Ehrhardt Clinical Research is conducting a randomized study to evaluate the efficacy and safety of study drug in patients with ulcerative colitis.
Qualified Participants Must:
• Have a diagnosis of ulcerative colitis established at least 6 months prior to screening
•
Have active moderate to severe ulcerative colitis
•
Be willing to undergo a screening colonoscopy
•
Not be currently taking any anti-TNF treatments such as remicade, Humira, Cimzia
Qualified Participants May Receive:
A stipend for time and travel
medical are throughout study participation